Ketamine Infusion for Treatment-resistant Major Depressive Disorder

NCT01582945 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

14

Enrollment

OTHER

Sponsor class

Conditions

Major Depressive Disorder

Interventions

DRUG: Ketamine

Sponsor

Massachusetts General Hospital